Market news

INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.

On August 6, Inogen (NASDAQ:INGN) reported second-quarter results that captured the company’s split personality right now. International sales keep compounding, new products are finding buyers, and profitability is improving. But the US business is still losing ground to a structural shift in how patients get oxygen therapy, and that weakness was enough to push full-year […]

INGN cuts its 2026 revenue outlook as U.S. channel pressure weighs, while international growth, new products and cost control offer support.

Inogen's steep sales-multiple discount, improving margins and firm international demand clash with U.S. sales and rental weakness.

Detailed price information for Inogen Inc (INGN-Q) from The Globe and Mail including charting and trades.

Moby summary of Inogen, Inc.'s Q2 2026 earnings call

BEVERLY, Mass., August 06, 2026--Reported second quarter revenue of $95.1 million. Company raises full-year adjusted EBITDA guidance to approximately $4.0 million

Motley Fool Press Release.

BEVERLY, Mass., July 16, 2026--Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026